We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Proposes Changes to Focus on Safety, Transparency in Drug Review Process
FDA Proposes Changes to Focus on Safety, Transparency in Drug Review Process
January 30, 2007
The FDA acknowledged the need for greater transparency and an increased focus on safety in its drug review process through a series of recommendations it issued late yesterday.